Skip to main navigation
Skip to search
Skip to main content
Rutgers, The State University of New Jersey Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Federal Grants
Research output
Search by expertise, name or affiliation
Nebulized β
2
-agonist use in high-risk inner-city adults with asthma
Jerry A. Krishnan
, Megan Demott
,
Jonathan V. McCoy
, Arjun Chanmugam
, Cynthia S. Rand
Research output
:
Contribution to journal
›
Article
›
peer-review
8
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Nebulized β
2
-agonist use in high-risk inner-city adults with asthma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
High Risk
100%
Asthma
100%
Inner City
100%
Nebulizer
100%
Asthma Symptoms
28%
Asthma Self-management
28%
Asthma Care
28%
Symptom Severity
14%
Number of Patients
14%
Substance Use
14%
Health Care Use
14%
Adult Age
14%
Between-group
14%
Symptom Relief
14%
Emergency Department
14%
Emergency Department Visits
14%
Severe Asthma
14%
Acute Asthma Exacerbation
14%
Asthma Morbidity
14%
Asthma Exacerbation
14%
Current Smoking
14%
Convenience Sampling
14%
Interviewer-administered
14%
Physician Diagnosis
14%
Controller Medication
14%
Severe Persistent Asthma
14%
Asthma Outcomes
14%
Acute Care Utilization
14%
City Emergency
14%
Self-management Practices
14%
Medicine and Dentistry
Asthma
100%
Nebulizer
77%
Emergency Department
22%
Asthma Exacerbation
22%
Cross Sectional Study
11%
Cigarette Smoking
11%
Severe Asthma
11%
Emergency Care
11%
Severe Persistent Asthma
11%
Moderate Persistent Asthma
11%
Diseases
11%
Immunology and Microbiology
Agonist
100%
Asthma
100%
Asthma Exacerbation
22%
Severe Asthma
11%
Severe Persistent Asthma
11%
Moderate Persistent Asthma
11%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Nebulizer
58%
Cigarette Smoking
8%
Cross-Sectional Study
8%
Severe Persistent Asthma
8%
Moderate Persistent Asthma
8%
Diseases
8%
Neuroscience
Agonist
100%
Substance Abuse
25%